Company news

Co-diagnostics, Inc. (NASDAQ:CODX) news

Co-diagnostics, Inc. news releases on 6ix. Latest, Oct 6, 2026: Co-Diagnostics to Showcase Co-Dx PCR Platform* and MTB Test at WHX Labs Johannesburg…

Co-diagnostics, Inc. (NASDAQ:CODX) news

Press releases & updates

Co-Diagnostics to Showcase Co-Dx PCR Platform* and MTB Test at WHX Labs Johannesburg, Highlight Ebola Assay Development

Co-Diagnostics to Participate in Global Health Events During UN General Assembly Week

Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation

Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026

Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola

Co-Diagnostics to Hold Press Conference

Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India

Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base

Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event

Co Diagnostics : Reports Second Quarter 2026 Financial Results

Co-Diagnostics Reports Second Quarter 2026 Financial Results

Co-Diagnostics Announces Second Quarter 2026 Earnings Release Date and Webcast

Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies

Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform

Co Diagnostics : Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer

Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand

Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States

Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line

Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement

Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara

Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert

Co-Diagnostics Reports First Quarter 2026 Financial Results

Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City

Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast

Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.

Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany

Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah

Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City

Co-Diagnostics Reports Full Year 2025 Financial Results

Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization

Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia

Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast

Co-Diagnostics to Present at Medical Korea 2026

Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies

Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships

Co-Diagnostics Announces Reverse Stock Split

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India

Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation

Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA

Co-Diagnostics Reports Third Quarter 2025 Financial Results

Utah Governor Cox and BioUtah Recognize Co-Diagnostics Following Recent JV Announcement in Kingdom of Saudi Arabia